Literature DB >> 26631630

Replacing and safeguarding pancreatic β cells for diabetes.

Jennifer E Bruin1, Alireza Rezania2, Timothy J Kieffer3.   

Abstract

Pluripotent stem cells are a scalable source of pancreatic cells for transplantation into patients with diabetes. Here, we describe how the field is gaining momentum toward a β cell replacement therapy.
Copyright © 2015, American Association for the Advancement of Science.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26631630     DOI： 10.1126/scitranslmed.aaa9359

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN： 1946-6234            Impact factor:   17.956


  16 in total

Review 1.  The quest to make fully functional human pancreatic beta cells from embryonic stem cells: climbing a mountain in the clouds.

Authors:  James D Johnson
Journal:  Diabetologia       Date:  2016-07-29       Impact factor: 10.122

Review 2.  Universal influenza virus vaccines: what can we learn from the human immune response following exposure to H7 subtype viruses?

Authors:  Daniel Stadlbauer; Raffael Nachbagauer; Philip Meade; Florian Krammer
Journal:  Front Med       Date:  2017-11-20       Impact factor: 4.592

3.  In vivo imaging of β-cell function reveals glucose-mediated heterogeneity of β-cell functional development.

Authors:  Jia Zhao; Weijian Zong; Yiwen Zhao; Dongzhou Gou; Shenghui Liang; Jiayu Shen; Yi Wu; Xuan Zheng; Runlong Wu; Xu Wang; Fuzeng Niu; Aimin Wang; Yunfeng Zhang; Jing-Wei Xiong; Liangyi Chen; Yanmei Liu
Journal:  Elife       Date:  2019-01-29       Impact factor: 8.140

4.  Islet cell transplant: Update on current clinical trials.

Authors:  Christian Schuetz; James F Markmann
Journal:  Curr Transplant Rep       Date:  2016-05-17

Review 5.  Report of the Key Opinion Leaders Meeting on Stem Cell-derived Beta Cells.

Authors:  Jon Odorico; James Markmann; Douglas Melton; Julia Greenstein; Albert Hwa; Cristina Nostro; Alireza Rezania; Jose Oberholzer; Daniel Pipeleers; Luhan Yang; Chad Cowan; Danwei Huangfu; Dieter Egli; Uri Ben-David; Ludovic Vallier; Shane T Grey; Qizhi Tang; Bart Roep; Camilo Ricordi; Ali Naji; Giuseppe Orlando; Daniel G Anderson; Mark Poznansky; Barbara Ludwig; Alice Tomei; Dale L Greiner; Melanie Graham; Melissa Carpenter; Giovanni Migliaccio; Kevin D'Amour; Bernhard Hering; Lorenzo Piemonti; Thierry Berney; Mike Rickels; Thomas Kay; Ann Adams
Journal:  Transplantation       Date:  2018-08       Impact factor: 4.939

6.  Senp2 expression was induced by chronic glucose stimulation in INS1 cells, and it was required for the associated induction of Ccnd1 and Mafa.

Authors:  Hye Seung Jung; Yu Mi Kang; Ho Seon Park; Byung Yong Ahn; Hakmo Lee; Min Joo Kim; Jin Young Jang; Sun-Whe Kim
Journal:  Islets       Date:  2016-09-20       Impact factor: 2.694

Review 7.  Engineering the gut for insulin replacement to treat diabetes.

Authors:  Majid Mojibian; Maria M Glavas; Timothy J Kieffer
Journal:  J Diabetes Investig       Date:  2016-03-14       Impact factor: 4.232

Review 8.  Genome-edited human stem cell-derived beta cells: a powerful tool for drilling down on type 2 diabetes GWAS biology.

Authors:  Nicola L Beer; Anna L Gloyn
Journal:  F1000Res       Date:  2016-07-15

9.  A programmable synthetic lineage-control network that differentiates human IPSCs into glucose-sensitive insulin-secreting beta-like cells.

Authors:  Pratik Saxena; Boon Chin Heng; Peng Bai; Marc Folcher; Henryk Zulewski; Martin Fussenegger
Journal:  Nat Commun       Date:  2016-04-11       Impact factor: 14.919

10.  Exendin-4 enhances the differentiation of Wharton's jelly mesenchymal stem cells into insulin-producing cells through activation of various β-cell markers.

Authors:  Dina H Kassem; Mohamed M Kamal; Abd El-Latif G El-Kholy; Hala O El-Mesallamy
Journal:  Stem Cell Res Ther       Date:  2016-08-11       Impact factor: 6.832
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.